The comprehensive therapy for primary liver cancer
- VernacularTitle:原发性肝癌420例综合治疗报告
- Author:
Shusen ZHENG
;
Yingsheng WU
;
Tingbo LIANG
- Publication Type:Journal Article
- Keywords:
Liver neoplasms;
Combined modality therapy;
Survival analysis
- From:
Chinese Journal of General Surgery
2000;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo verify the effect of comprehensive therapy for primary liver cancer (PLC). MethodsThe clinical data of 420 cases admitted to our hospital from Jan. 1994 to Jun. 2000 was analyzed retrospectively. Patients received hepatectomy and transarterial chemoembolization (TACE), drug delivery system (DDS) on case-to-case basis.Results Three hundred and twenty-seven patients were followed-up from 3 days to 81 months. The overall 1-, 3-, 5-year survival rates were 40.9%、19.1%、12.4%, respectively. 75.9%,47.3%,40.1% for patients undergoing radical resection and 39.6%,22.1%,17.5% in patients with palliative resection. TACE or DDS implantation after palliative resection was effective to enhance the survival rate. Conclusion The rational and scientific combination of multiple modality is important to prolong survival time of the patients with PLC.
